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Abstract
Background: The low luminal Ca2+ concentration of mammalian endolymph in the inner ear is required for
normal hearing and balance. We recently reported the expression of mRNA for a Ca2+-absorptive transport system
in primary cultures of semicircular canal duct (SCCD) epithelium.
Results: We now identify this system in native vestibular and cochlear tissues by qRT-PCR, immunoblots and
confocal immunolocalization. Transcripts were found and quantified for several isoforms of epithelial calcium
channels (TRPV5, TRPV6), calcium buffer proteins (calbindin-D9K, calbindin-D28K), sodium-calcium exchangers
(NCX1, NCX2, NCX3) and plasma membrane Ca2+-ATPase (PMCA1, PMCA2, PMCA3, and PMCA4) in native SCCD,
cochlear lateral wall (LW) and stria vascularis (SV) of adult rat as well as Ca2+ channels in neonatal SCCD. All
components were expressed except TRPV6 in SV and PMCA2 in SCCD. 1,25-(OH)2vitamin D3 (VitD) significantly up-
regulated transcripts of TRPV5 in SCCD, calbindin-D9K in SCCD and LW, NCX2 in LW, while PMCA4 in SCCD and
PMCA3 in LW were down-regulated. The expression of TRPV5 relative to TRPV6 was in the sequence SV > Neonatal
SCCD > Adult SCCD > LW > primary culture SCCD. Expression of TRPV5 protein from primary culture of SCCD did
not increase significantly when cells were incubated with VitD (1.2 times control; P > 0.05). Immunolocalization
showed the distribution of TRPV5 and TRPV6. TRPV5 was found near the apical membrane of strial marginal cells
and both TRPV5 and TRPV6 in outer and inner sulcus cells of the cochlea and in the SCCD of the vestibular system.
Conclusions: These findings demonstrate for the first time the expression of a complete Ca2+ absorptive system in
native cochlear and vestibular tissues. Regulation by vitamin D remains equivocal since the results support the
regulation of this system at the transcript level but evidence for control of the TRPV5 channel protein was lacking.
Background
The calcium concentration of the inner ear luminal
fluid, endolymph (cochlea 23 μM and vestibule 280
μM), is much lower than that of the basolateral fluid,
perilymph (ca. 1 mM) [1]. The low Ca2+ level is essential
for the normal transduction of sound and acceleration
for hearing and balance [2]. It has been assumed that
there likely are one or more Ca2+ absorptive mechan-
isms in the inner ear. We previously demonstrated that
transcripts of a novel Ca2+ absorptive system are
expressed in primary cultures of rat semicircular canal
duct (SCCD).
The Ca2+ absorptive system [3] is comprised of an
apical membrane entry pathway (the Ca2+-selective
TRPV5 and/or TRPV6 channel), a cytosolic Ca2+ buffer
protein (calbindin-D9K and calbindin-D28K), and baso-
lateral Ca2+ exit pathways (sodium-calcium exchangers
(NCX) and plasma membrane Ca2+-ATPases (PMCA)).
Expression of these transporters can be regulated by the
active form of vitamin D, 1,25-(OH)2vitamin D3 [4]. Ca
2
+ that enters the cell through the apical TRPV5/6 chan-
nel is buffered by the calbindin and transported by dif-
fusion in bound form across the cell, from which it is
released across the basolateral cell membrane via the
PMCA and NCX transporters. The predominant apical
channel in kidney is TRPV5 and in the intestine it is
TRPV6 [4].
Observations of this transport system in the ear have
been limited to transcript expression in primary cultures
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of rat SCCD for all of the transport system genes [5],
immunolocalization in mouse cochlea and vestibular
labyrinth of TRPV5 and TRPV6 [6], and radiolabeled
Ca2+ fluxes in primary cultures of rat SCCD [7].
The questions remained whether 1) the system of
epithelial Ca2+ transport genes was also expressed in the
cochlea, 2) whether native inner ear tissues expressed
the same constellation of genes as the primary cultures
of SCCD, 3) whether transcript expression in rat tissues
resulted in protein expression of epithelial Ca2+ channel
genes with a distribution similar to mouse and 3)
whether tissues from each represented region of the
inner ear that express epithelial Ca2+ transport genes
responded to 1,25-(OH)2vitamin D3. The present study
addressed those questions. Evaluation of protein expres-
sion used primary cultures to obtain sufficient material
for immunoblots and used sections of rat cochlea and
SCCD for immunostaining.
Results
The “primary cultures” of SCCD refer to epithelial cells
from neonatal SCCD that have been seeded on perme-
able supports and have proliferated to confluence over 5
or more days. The proliferation and re-differentiation in
vitro and the attachment to a new surface all carry the
risk of altered gene expression compared to canals in
vivo. The tissues that we refer to as “native” were
explants that were incubated for only 24 hours in vitro,
that experienced no changes to proliferative and re-dif-
ferentiation phases nor attachment to a new surface.
The acute incubation of the explants was necessary to
study possible changes to gene expression in response
to vitamin D and for an untreated control series.
mRNA expression
Levels of transcript expression for all components and
isoforms of the epithelial calcium absorption pathway
are shown in Fig. 1 for isolated native tissues from the
vestibular labyrinth (semicircular canal; SCCD) and
cochlea (stria vascularis and lateral wall exclusive of
stria). Results from primary cultures of neonatal SCCD
[5] are shown for reference.
The epithelial calcium channel TRPV5 was expressed
in all tissue fractions, while TRPV6 was expressed in all
tissue fractions except stria vascularis. The absolute
quantities of each gene transcript cannot be unambigu-
ously compared since the efficiency of the RT step for
each primer is not known. However, the ratios between
the apparent TRPV5 and TRPV6 transcripts can be
compared among tissues. The apparent TRPV5:TRPV6
transcript expression ratio in adult SCCD was 3.2, neo-
natal SCCD was16, much higher in stria vascularis since
TRPV6 was not detectable but only 1.8 in the lateral
wall. The high TRPV5:TRPV6 ratio in adult SCCD
compared to neonatal primary cultures ([5] and Fig. 1)
was not a result of changes during development. TRPV5
in native neonatal SCCD was expressed at 16 times the
level of TRPV6 (TRPV5 = 4.7 × 10-3, n = 12; TRPV6 =
2.9 × 10-4, n = 10; normalized to 10,000 18S). The
expression of TRPV5 relative to TRPV6 is therefore in
the sequence Stria vascularis > Neonatal SCCD > Adult
SCCD > cochlear lateral wall > primary culture SCCD.
The calcium-buffering calbindin proteins, calbindin-
D9K and calbindin-D28K, were expressed in native
SCCD, lateral wall and stria vascularis of adult rat as
well as in primary culture SCCD (Fig. 1). The relatively
low gene expression levels reported here likely reflects a
low reverse transcription efficiency of the primers but
may also reflect a low level of transcript expression. All
isoforms of the sodium-calcium exchanger (NCX1,
NCX2 and NCX3) were expressed as mRNA by all
native tissues as well as by cultured SCCD (Fig. 1). All
four isoforms of the plasma membrane calcium ATPase
(PMCA) were found in the cochlear tissues, while only
three isoforms (not PMCA2) were found in the SCCD
(native and cultured) (Fig. 1). The relatively low level of
expression of PMCA2 in stria vascularis suggests a
minor role in the function of this tissue and could con-
ceivably represent a low level of contamination from
other tissues. Vitamin D receptor transcripts were found
in all native tissues (Fig. 1) as well as in primary cultures
of SCCD.
Addition of 1,25-(OH)2vitamin D3 for 24 h increased
the expression of TRPV5 in native SCCD (× 3.2), as in
primary cultures [5], but not significantly in lateral wall
or stria vascularis (Fig. 1). Calbindin-D9K was signifi-
cantly up regulated by 1,25-(OH)2vitamin D3 in native
SCCD (× 3.4) and lateral wall (× 8.9) but not in stria
vascularis (× 13.9; P = 0.059). 1,25-(OH)2vitamin D3 did
not significantly up-regulate the expression of calbindin-
D28K in any of the native tissues, even though it did in
primary cultures of SCCD (Fig. 1). NCX2 in the lateral
wall was the only sodium-calcium exchanger that was
up-regulated (× 101) by 1,25-(OH)2vitamin D3. None of
the PMCAs were up-regulated by 1,25-(OH)2vitamin D3,
while there were small but significant decreases of
PMCA4 in SCCD and of PMCA3 in lateral wall. 1,25-
(OH)2vitamin D3 exposure did not significantly change
the expression level of the vitamin D receptor in any
tissues.
Protein expression of TRPV5: immunoblot
TRPV5 protein migrated to about 80 kDa (linear inter-
polation) for cultured SCCD as well as native kidney
cortex (positive control) of neonatal rat but not in kid-
ney papilla (negative control; (Fig. 2A). Pretreatment of
the primary antibody with antigenic peptide (Fig. 2B)
markedly reduced the intensity of the 80 kDa band,
whereas the band near 120 kDa was not blocked with
antigenic peptide. Non-specific bands appeared
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Figure 1 Summary of expression of transcripts for isoforms of epithelial Ca2+ channels (TRPV5 and TRPV6), calbindin, NCX, PMCA and
VDR with and without exposure to 1,25- (OH)2vitamin D3. Expression levels given as ratio of specific gene to 18S in primary cultures of
semicircular canal duct (SCCD), native SCCD, native lateral wall (LW) and native stria vascularis (SV). All native tissues were incubated overnight
after microdissection in order to reduce extracellular cross-contamination from RNA released from adjacent tissues (see Fig 1B). Open bars;
control, hatched bars; 1,25-(OH)2vitamin D3 treated, Significant up- or down-regulation is indicated; *, P < 0.05; ND, not detected. For
comparison, data in the left section are primary culture of SCCD, reproduced from [5].
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sporadically at 65 kDa in kidney and SCCD. The sugges-
tion of a double band (80 kDa and ~100 - 120 kDa) in
SCCD could represent two types of post-translational
modification, two levels of glycosylation or non-specific
labelling of the upper band. The 80 kDa band is similar
in size to the calculated molecular weight of TRPV5,
82.4 kDa. Exposure to 1,25-(OH)2vitamin D3 did not
significantly increase protein expression of TRPV5 in
the primary cultured cells. Xenopus leavis oocytes trans-
fected with human TRPV5 cDNA showed 2 additional
bands for TRPV5 and they were sensitive to PNGase F
[8]. By contrast, there were no bands from SCCD that
were susceptible to PNGase F treatment (Fig. 2C). The
antibody for TRPV6 did not react with specific bands in
immunoblots.
Protein expression of TRPV5 and TRPV6:
immunohistochemistry
The distribution of the epithelial calcium absorptive
system was examined in more detail by immunostain-
ing of cochlear and vestibular structures for TRPV5
and TRPV6 (Fig. 3). In the vestibular system (Fig. 3A,
B), the only staining of epithelial cells was observed in
the SCCD. The SCCD epithelial cells are only 1 μm
tall, making it difficult to clearly discern differential
staining of the apical and basolateral membrane for
low copy number membrane proteins. We visualized
specific labeling of TRPV5 and TRPV6 in the SCCD by
opening the pin-hole of the confocal microscope in
order to integrate the signal over a greater area and
depth (Fig. 3A,B). The specificity of the signal was
assured by the total absence of staining of the sur-
rounding bone and of sections prepared in the absence
of primary antibody (not shown). No epithelial staining
was seen in the utricle or ampullae (not shown). Phal-
loidin staining aided the identification of epithelial
cells by the location of the actin ring associated with
the tight junction complex.
In the cochlea (Fig. 3C,D,E), strong immunostaining
for TRPV5 and TRPV6 was observed in both the inner
sulcus and outer sulcus epithelial cells, as well as the
Hensen’s cells medial to the outer sulcus (Fig. 3C,D).
The outer sulcus is part of the “lateral wall” fraction
included in the mRNA determinations. The observations
of TRPV5 and TRPV6 protein expression in the inner
sulcus and Hensen’s cells extends our knowledge of the
expression pattern. Marginal cells of the stria vascularis
were labeled for TRPV5 (Fig. 3E) but not TRPV6 (not
shown) protein expression near the apical membrane.
The staining in stria vascularis for TRPV5 was repeata-
ble but variable. When the stria vascularis was immu-
noreactive, the marginal cells were strongly stained (Fig.
3E).
Discussion
The level of endolymphatic [Ca2+] is controlled by both
secretory mechanisms (e.g., PMCA2 in the apical surface
of hair cells [9]) and absorptive mechanisms. The pre-
sent paper reports the first evidence for the expression
of all genes necessary to constitute a complete transe-
pithelial Ca2+ absorptive pathway in native tissues of the
inner ear. We previously reported that cochlear outer
sulcus cells and vestibular transitional cells have apical
nonselective cation channels that are likely permeable to
Ca2+ [10,11], but their contribution to transepithelial
Ca2+ absorption is not known.
Expression
The transmural absorption of Ca2+ by a number of
epithelia has recently been ascribed to a set of genes
that encode the apical entry channels TRPV5 and
TRPV6, the cytosolic Ca2+ buffering proteins calbindin-
D9K and calbindin-D28K, and the basolateral Ca2
+-extruding transporters sodium-calcium exchangers
(NCX) and plasma membrane calcium ATPases
(PMCA) [3]. In other epithelial, either TRPV5 or
TRPV6 is expressed at a higher level, but in spite of the
large array of epithelia surveyed previously [3], expres-
sion of this transport system in the inner ear was not
reported. We demonstrated here that all components of
the epithelial Ca2+ channel transport system were found
to be expressed as transcripts in the vestibular SCCD
and cochlea.
Our results validate the primary culture of SCCD in
terms of the presence of all the genes that participate in
Ca2+ absorption and regulation, although the relative
expression level of TRPV5 and TRPV6 was observed to
be substantially reduced in culture compared to the
native cells. This apparent discrepancy is consistent with
the lack of 1,25-(OH)2vitamin D3 in the control culture
medium (see below), whereas the native tissues were
exposed to intermediate levels of the hormone in vivo
prior to sacrifice. TRPV5 and TRPV6 form homo- and
hetero-tetrameric channel complexes and regulation of
the relative expression levels of TRPV5 and TRPV6 may
be a mechanism for fine-tuning Ca2+ transport kinetics
in TRPV5/6-expressing tissues [12].
Quantification of expression levels has intrinsic pro-
blems. First, there can be large discrepancies between
levels of transcripts and levels of the corresponding pro-
teins. Further, the proteins can receive various post-
translational modifications and trafficked to different
destinations with a consequent multiplicity and altered
level of function. Second, seemingly anomalous results
due to imprecision of Ct determination in RT-PCR and
its logarithmic relation to transcript number can occur,
leading to calculated large fold-changes in expression
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Figure 2 TRPV5 protein detected by immunoblot. Incubation of primary cultures of SCCD for 24 h in the absence and presence of 100 nM
1,25- (OH)2vitamin D3. Protein expression of TRPV5 was compared with b-actin. A) Cultured SCCD cells with or without 1,25-(OH)2vitamin D3;
kidney cortex and papilla were used for positive and negative controls. The blot was stripped of TRPV5 antibody and re-probed for beta-actin. B)
Antigenic peptide blocked 80 kDa band. A band at 42 kDa is b-actin. The blot was directly probed for beta-actin without stripping since the
TRPV5 antibody did not produce bands at the molecular weight of actin. C) PNGase F did not affect any TRPV5 bands. A band at 36 kDa is
PNGase F itself. D) Intensity of 80 kDa TRPV5 bands standardized to b-actin. The mean intensity in 1,25-(OH)2vitamin D3 treated cells was larger
but not statistically significant. Ctrl, control; Vit.D, 1,25-(OH)2vitamin D3 ; ns, P > 0.05; n = 14 each condition.
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Figure 3 Epithelial calcium channel immunolocalization in the cochlea and vestibular system of rat. Double-staining with an antibody
against TRPV5 or TRPV6 (green) and actin (red; phalloidin) (A-D) and single-staining with an antibody against TRPV5 (green) (E). A, B) Cross
sections of SCCD were stained against TRPV5 and TRPV6. C) Cross section of cochlea was stained against TRPV5. Outer sulcus cells (OS), inner
sulcus cells (IS) and Hensen’s cells (left of OS) show significant staining for TRPV5. D) Cross section of cochlea was stained against TRPV6. Outer
sulcus cells, inner sulcus cells and Hensen’s cells show significant staining for TRPV6. E) Cross section of stria vascularis (SV). Marginal cells of stria
vascularis (arrows) show staining for TRPV5 at the apical membrane. Sections exposed to primary antibodies preabsorbed with antigenic peptide
were not stained (not shown). RM, Reissner’s membrane; L, spiral limbus; SL, spiral ligament.
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that do not reach statistical significance (e.g., calbindin-
D9K in stria vascularis; vide infra).
TRPV5 and TRPV6 gene expression in the inner ear
was also demonstrated at the level of protein. Sufficient
protein could be obtained from primary cultures of
SCCD to allow immunoblot observation of TRPV5.
Interestingly, immunoblot data did not show a signifi-
cant difference in TRPV5 expression between control
and 1,25-(OH)2vitamin D3 treated SCCD cells. This
result is not consistent with the functional data from
the same preparation that show an upregulation by
1,25-(OH)2vitamin D3 of radiolabeled Ca
2+ fluxes in pri-
mary cultures of SCCD [7]. The apparent discrepancy
could be accounted for by 1) the increased transcript
expression not affecting protein amount and 2) an upre-
gulation by 1,25-(OH)2vitamin D3 of another controlling
part of the transport system. The ineffectiveness of
PNGase F treatment for TRPV5 suggests the occurrence
of other posttranslational modifications than glycosyla-
tion or a low abundance of glycosylated protein.
Immunolocalization of both epithelial Ca2+ channels
was consistent with the transcript data for both the ves-
tibular system and for the cochlea. In addition to the
cochlear localization of the strial marginal cells and the
outer sulcus of the lateral wall, these channels were also
observed in the inner sulcus epithelial cells of the rat
inner ear. Recent observations in mouse show similar
cellular locations, although the preponderance of
TRPV5 or TRPV6 in some cells differs [6]. Our data
demonstrate that the earlier findings were not strictly
limited to one species. The antibodies used do not
restrict their binding to membrane proteins, so that
there is staining of protein in the cytosol, preventing the
subcellular localization of TRPV5 and TRPV6 to the
apical and/or basolateral membranes. In addition, the
antibody against TRPV6 did not function in
immunoblots.
The other genes required for Ca2+ absorption–calbin-
din-D9K, calbindin-D28K, NCX1 and PMCA1b–were
previously found to be involved in Ca2+ absorption by
the kidney [13,14]. Calbindin-D9K can prevent calcium-
dependent inactivation of TRPV5/6 by buffering over-
loaded Ca2+ beneath the apical side while calbindin-
D28K is freely diffusible in the cytoplasm [4]. We evalu-
ated all isoforms of NCX1-3 and PMCA1-4 in the inner
ear tissues.
PMCA was demonstrated by immunohistochemistry
to be present in the basolateral membrane of strial mar-
ginal cells and Reissner’s membrane epithelial cells [15].
NCX1 and PMCA1 were the predominant isoforms
expressed in the inner ear, as in the kidney. However,
other isoforms were also found to be present. PMCA2
was not expressed in either native or cultured SCCD
and virtually absent in stria vascularis. Absence of
PMCA2 in stria vascularis is compatible with previous
reports [9,16]. Expression of PMCA2 in the lateral wall
fraction might arise from contributions by Reissner’s
membrane [16]. PMCA2 is therefore not likely impor-
tant for inner ear Ca2+ absorption; rather its function is
likely limited to Ca2+ secretion at the apical membrane
of hair cells [9,17] and possibly Reissner’s membrane
[16].
Our detection of PMCA3 and PMCA4 in all tissue
fractions is at variance with previous reports for the
cochlea [9,16]. It is possible to attribute these discrepan-
cies to species differences. A previous immunohisto-
chemical study showed calbindin-D28k expression in
musk shrew spiral ganglion, inner and outer hair cells,
but expression in lateral wall was only observed during
pre-natal ages [18]. By contrast, we observed expression
of calbindin-D28k in lateral wall fractions of young
adult rats.
Regulation
A wide range of signal pathways converge to control Ca2
+ absorption. An important control mechanism is regu-
lation of the number of expressed apical entry Ca2+
channels and calbindins by 1,25-(OH)2vitamin D3. It is
apparently characteristic of different epithelia that 1,25-
(OH)2vitamin D3 up-regulates predominantly one chan-
nel isoform through activation of the vitamin D receptor
[3]. Caco-2 cells up-regulate TRPV6 in a time- and
dose-dependent manner [19]. By contrast, 1,25-(OH)
2vitamin D3 up-regulates TRPV5, but not TRPV6, in
kidney [3] and SCCD (vide infra).
Two isoforms of calbindin, calbindin-D9K and -D28K,
are expressed in the inner ear epithelia and calbindin-
D9K transcript expression is up-regulated by 1,25-(OH)
2vitamin D3. It has been shown that calbindin-D9K is
localized near both the apical and basolateral plasma
membranes [20], while calbindin-D28K is freely diffusi-
ble in the cytoplasm [20] but translocates to the apical
membrane to associate with the TRPV5 [21]. One func-
tion of calbindin-D28K is to prevent Ca2+ from binding
to calmodulin, which can block TRPV6 by binding to
the COOH-terminal region [22]. Interaction with either
channel is important since the functional channel is
likely a tetraheteromer of TRPV5/TRPV6. Both calbin-
dins, NCX1 and PMCA1b genes were up-regulated in
hormone-deficient 1a-OHase-/- mice by 1,25-(OH)2vita-
min D3 [20].
NCX and PMCA isoform expression levels were not
uniformly changed by 1,25-(OH)2vitamin D3 in the
SCCD, lateral wall and stria vascularis. NCX2 in the lat-
eral wall may be important for the Ca2+ absorption
pathway because of its up-regulation by 1,25-(OH)2vita-
min D3. But the reason why PMCA4 in SCCD and
PMCA3 in lateral wall were down-regulated is not clear.
The lack of response of all genes in the stria vascularis
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may indicate that this transport system is not functional
in stria. Alternatively, it may represent a vitamin D-
insensitive transport system in this tissue.
The activity of the TRPV5 and TRPV6 channels is
steeply controlled by both intra- and extracellular pH
[23]. The strong inhibition by acid extracellular pH is of
particular interest in view of pathologic conditions lead-
ing to lowered pH in both cochlear and vestibular endo-
lymph (see below). Epithelial Ca2+ channel activity can
further be controlled by PIP2, providing a link to a vari-
ety of G protein-coupled receptors [24].
Physiological significance
The question naturally arises whether this transport sys-
tem is relevant at the whole organ level. Several obser-
vations demonstrate the functionality of this system and
point to its importance in hearing and balance. It was
recently shown that SCCD epithelial cells take up radi-
olabeled Ca2+ more rapidly from the apical side than
from the basolateral side, that the net uptake is
increased in the presence of 1,25-(OH)2vitamin D3 and
that the apical uptake is inhibited by acidic luminal pH
(a hallmark of TRPV5 and TRPV6) [7]. It was therefore
predicted that any condition that results in an acidifica-
tion of endolymph would also lead to increased luminal
[Ca2+] and a consequent decrease in cochlear and ves-
tibular function, which depend on the normally low
endolymphatic [Ca2+] [2]. Indeed, mutations or deletion
of the bicarbonate-secreting transporter pendrin
(expressed in the luminal membranes of cochlear and
vestibular epithelial cells) lead to hearing and balance
deficits in humans [25] and mice [26]. Deletion of pen-
drin led to acidified endolymph and consequently a dra-
matic elevation of endolymphatic [Ca2+] in both the
cochlea [6] and the utricle [7]. This observation suggests
that the TRPV5/6 Ca2+ absorption system plays a highly
significant physiological role in endolymph Ca2+ home-
ostasis, even though the endocochlear potential appar-
ently plays a strong role by providing a driving force for
passive efflux [27].
Calcium homeostasis in the inner ear via TRPV5/6
could play an important role in causes of benign parox-
ysmal positional vertigo (BPPV) and may therefore be
an effective drug target. BPPV is characterized by brief
episodes of nystagmus and vertigo in response to certain
movements of the head. It is thought to be caused by
dislodged otoliths (composed primarily of CaCO3 crys-
tals) from the utricle that enter one of the semicircular
canals, leading to inappropriate stimulation of canal. A
recent study reported that strong correlations in human
patients were observed between diagnosis of BPPV and
disturbed calcium homeostasis as reflected in reduced
bone mineral density [28].
Vitamin D has been implicated in hearing function.
Ikeda and associates found that vitamin D deficiency
resulted in hearing impairment in rats [29] and that 80%
of patients in a study with bilateral sensory neural hear-
ing loss (BSNHL) were found to be deficient in 1,25-
(OH)2vitamin D3 [30,31]. Importantly, the patients with
BSNHL and low serum vitamin D had normal serum
Ca2+, consistent with a local effect of vitamin D defi-
ciency in the auditory and vestibular periphery. The
vitamin D-deficient rats had a reduced perilymphatic
[Ca2+] level, making the interpretation less clear. It was
not known whether the observed effects were due to
direct effects on the epithelial calcium channel system
(not known at that time), to the lowered systemic [Ca2
+], or to other causes. Nonetheless, the correlations are
consistent with a direct action on the system reported
here.
The dysfunction of Ca2+ absorption by mutation or
absence of the TRPV5 and TRPV6 genes would be
expected to lead to impaired hearing and balance. It is
perhaps more than a coincidence, therefore, that the
genes for TRPV5 and TRPV6 are located on chromo-
some 7q35 and 7q33-34 respectively in human [4] and
the locus of the non-syndromic deafness gene [32]
DFNB13 is located at the encompassing region on chro-
mosome 7q34-36 [33].
Conclusions
Both the cochlea and the vestibular system were found
to express all genes needed to constitute a Ca2+ absorp-
tion mechanism that can maintain the low levels of
endolymphatic [Ca2+] needed to sustain normal hearing
and balance. The native semicircular canal expresses all
of the Ca2+ transport genes found previously in the cul-
ture system. No other epithelial cells in the vestibular
system were found to express epithelial Ca2+ channels.
Specific cochlear epithelial cells that express TRPV5 and
TRPV6 include those of the inner and outer sulcus and
Hensen’s cells. Strial marginal cells of the cochlea also
express TRPV5 but not TRPV6. These components of
the epithelial Ca2+ absorption pathway likely play an
important role in Ca2+ homeostasis of endolymph.
Methods
Tissue isolation and incubation
Temporal bones were obtained from adult (3-5 weeks)
or neonatal (3-8 d) Wistar rats according to a protocol
approved by the Kansas State University Institutional
Animal Care and Use Committee. SCCD were microdis-
sected from the bony canal, excluding the common
crus. Cochleae were microdissected and stria vascularis
tissue was isolated by peeling carefully from spiral liga-
ment under microscopic control. The rest of the lateral
wall, including spiral ligament, Reissner’s membrane,
spiral prominence and outer sulcus cells was collected
as “lateral wall”.
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Isolated tissues from adult animals and dispersed
SCCD epithelial cells from neonatal animals were incu-
bated on permeable supports in DMEM/F-12 medium
(Invitrogen 12500-062 Carlsbad, CA), 5% fetal bovine
serum, 100 U/ml penicillin, and 100 μg/ml streptomy-
cin) in 5% CO2 atmosphere at 37°C as described pre-
viously [34]. Culture inserts were 6.5 mm diameter
Transwells (Costar #3470, Corning, NY) for RNA isola-
tion and 12 mm Snapwell inserts (Costar #3801) for
protein isolation.
Isolated intact tissues did not proliferate in acute (24
h) culture but dispersed SCCD cells proliferated rapidly
to confluence (primary cell culture), typically within
about 5 days. Intact explants of isolated tissues were
incubated (24 h) in the presence or absence of 1,25-
(OH)2vitamin D3 (100 nM DM-200; BIOMOL, Ply-
mouth Meeting, PA; dissolved in 0.1% ethanol); incuba-
tion with 0.1% ethanol was used as control.
RNA Isolation
Total RNA was extracted from the tissue explants or
SCCD primary culture cells using QIAshredder Mini
Spin Column (79654, Qiagen, Valencia, CA) and RNeasy
Micro Kit following the manufacturer’s protocol
(#74004, Qiagen, Valencia, CA). Total RNA quality was
determined with an Agilent BioAnalyzer (Model 2100,
Palo Alto, CA) with RNA 6000 Nano/Pico Assay Kits
(5065-4473/5065-4476, Agilent technology) (See Addi-
tional File 1: Fig. S1) and quantity was determined with
a Nanodrop ND-1000 Spectrophotometer (NanoDrop
Technologies, Delaware, USA), using a conversion factor
of 1 absorption unit normalized to 1.0 cm path length =
40 ng/μl at 260 nm wavelength.
Contamination of mRNA
Two strategies were followed for minimization of con-
tamination of samples by adherent extracellular RNA
from other cells ruptured during dissection, a potential
problem in RNA collection from microdissected hetero-
geneous tissues [35]. Multiple rinses of tissues were fol-
lowed by acute incubation of samples. The effectiveness
of acute incubation on degradation of adherent extracel-
lular RNA was tested. Total RNA from rat kidney (7926
Ambion, Austin, TX) was incubated in vials and stored
at either 4°C or 37°C for 24 hours. The quality of RNA
was subsequently evaluated by Agilent BioAnalyzer. Fig.
S1 (See Additional File 1: Fig. S1) shows marked degra-
dation of RNA in the sample incubated at 37°C, sup-
porting the efficacy of this treatment in preventing or
reducing potential contamination from adjacent tissues
during dissection.
Quantitative real-time RT-PCR
Primers for TRPV5, TRPV6, calbindin-D9K, calbindin-
D28K, NCX1, NCX2, NCX3, PMCA1, PMCA2, PMCA3,
PMCA4, vitamin D receptor and 18S were used as
described previously [5] and real time RT-PCR was
performed by the same procedure and analyzed as
described [26]. All PCR reactions were carried out in a
final volume of 25 μl in a real-time thermocycler (Smart
Cycler, Cepheid, Sunnyvale, CA). The reaction mix con-
sisted of Master Mix (OneStep RT-PCR kit;210210, Qia-
gen), 0.2× SYBR green 1 (# S7567, Molecular Probes),
and 600 nM of each gene-specific forward and reverse
primer. Reverse transcription was performed for 30 min
at 50°C followed by 15 min at 95°C. PCR conditions
used were: denature at 95°C for 60 s, annealing at 51°C
- 60°C for 60 s with an extension at 72°C for 60 s,
amplified for 50 cycles. Hot-measurements that are 3-5°
C below product melting temperature were performed
to eliminate signal contamination by primer-dimers
[26]. To exclude the possibility of genomic DNA ampli-
fication during the PCR reaction, RT-negative controls
were performed. PCR products were run on 2% agarose
gels and detected by ethidium bromide or with the Bioa-
nalyzer 2100 with DNA 1000 Assay Kit (5065-4449, Agi-
lent Technology). All PCR products displayed a specific
band on agarose gel or a specific peak on the Bioanaly-
zer electropherogram. PCR products were purified
(28104, Qiagen) and the purified products were
sequenced to verify the identity of the RT-PCR pro-
ducts. The expression level of genes was evaluated by
quantitative real-time RT-PCR using 0.5 - 5 ng total
RNA per reaction. Transcripts of 18S rRNA and target
genes were amplified as described using gene-specific
primers. The specific gene expression was normalized to
the level of 18S in each sample as described previously
[26], taking into account the fidelity of each PCR
reaction.
An example of real time RT-PCR results for native
SCCD (See Additional File 1: Figure S1) shows cycle-
fluorescence growth curves of 18S (dashed line), TRPV5
of control (dotted line) and 1,25-(OH)2vitamin D3 trea-
ted epithelia (solid line). Cycles at threshold = 30 are
about 16 for 18S, 32 for TRPV5 of control and 30 for
TRPV5 of 1,25-(OH)2vitamin D3 treated, demonstrating
an increase in expression of TRPV5 transcripts after
1,25-(OH)2vitamin D3 treatment.
Immunoblots
Western blots were prepared by methods similar to
those described previously [36]. Primary cultures of
SCCD were used in order to obtain sufficient protein
for analysis (see above). SCCD monolayers from three
Snapwell inserts for each experimental condition were
washed three times in phosphate buffered saline (PBS;
150 mM NaCl, 8 mM Na2HPO4·2H2O, 2 mM KH2PO4,
pH 7.4) at 37°C and then lysed in cold (4°C) RIPA buf-
fer (10 mM Tris base, 1% sodium deoxycholate, 1% Ter-
gitol (NP40S, Sigma St Louis, MO), 150 mM NaCl, pH
7.9) containing 1% protease inhibitor cocktail (P2714,
Sigma). Rat kidney cortex and papilla whole cell lysates
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were obtained from young (3 week) Wistar rats. Tissue
was frozen in liquid nitrogen, crushed and homogenized
using a mortar and pestle in cold (4°C) RIPA buffer con-
taining protease inhibitors and used as controls. The
supernatant was collected after being stored at 4°C for
one hour, centrifuged at 15,000 g for 5 min at 4°C; the
protein concentration was determined with a Nanodrop
ND-1000 Spectrophotometer using the conversion of 1
absorbance unit at 280 nm wavelength = 1 mg protein/
ml and stored at -80°C for later use.
Total SCCD protein amounts were prepared to be
equal for each gel lane. After being diluted in 1×
Laemmli sample buffer (#161-0737, Bio-Rad, Hercules,
CA) containing 5% 2-mercaptoethanol (#M-7154,
Sigma), samples were heated for 15 min at 75°C. Pro-
teins were separated using 4-15% Tris-HCl precast poly-
acrylamide gels (#161-1104, Bio-Rad) at 140 V for 60
min using running buffer [25 mM Tris-Base, 192 mM
glycine and 0.1% SDS](#161-0732, Bio-Rad). A colored
marker mixture (#161-0375, Bio-Rad) was used for esti-
mation of molecular weight. After electrophoresis, pro-
teins were transferred onto a PVDF membrane (#162-
0175, Bio-Rad) using the XCell II Blot Module semi-wet
transfer unit (#EI0002, Invitrogen) at 24 V for 75 min
using transfer buffer [25 mM Tris-Base, 192 mM gly-
cine, 20% methanol, pH 8.3]). The membrane was then
blocked with a blocking buffer (5% non-fat dry milk
[#170-6404, Bio-Rad] in TBS [20 mM Tris-Base, 137
mM NaCl, pH 7.6] containing 0.05% Tween 20) for 1 hr
at room temperature and then probed overnight at 4°C
with 1:400 primary antibody (TRPV5, #CAT21A, Alpha
Diagnostics, San Antonio, TX). For standardization,
membranes were stripped using Restore Western Blot
Stripping Buffer (#21059, Pierce) and then reprobed
with anti-actin antibody (1:1000, #A2066 Sigma) for 1
hr at room temperature. Horseradish peroxidase-conju-
gated secondary donkey anti-rabbit IgG (#NA934V
Amersham Biosciences, Piscataway, NJ) was diluted to
1:5,000 in blocking buffer and then used to incubate the
membrane for 1 hr at room temperature. Antigenic pep-
tide for TRPV5 (#CAT21P, Alpha Diagnostics, 1: 36)
was used to validate antibody specificity. Finally, mem-
branes were treated with a chemiluminescent substrate
(SuperSignal West Pico Substrate #34080 for actin &
SuperSignal West Femto Maximum Sensitivity Substrate
#34095 for TRPV5, Pierce, Rockford, IL) and digitally
imaged with a Kodak IS4000R image station.
The intensity of each band was analyzed using Mole-
cular Imaging Software version 4.0.5 (Kodak, Rochester,
NY). The intensity of signals was obtained by dividing
TRPV5 signals by corresponding actin signals. To com-
pare the expression of TRPV5 in the presence and
absence of 1,25-(OH)2vitamin D3 among different mem-
branes, the average intensity of control (absence of 1,25-
(OH)2vitamin D3) bands at each molecular mass on
each membrane was normalized to 1.
Glycosylation
SCCD protein samples were treated with Peptide: N-
Glycosidase F (PNGase F) following the manufacturer’s
instruction (#P0704S; New England Biolabs, Ipswich,
MA). Equal amounts of lysates were denatured at 100°C
for 10 min in the presence of glycoprotein denaturing
buffer. After adding reaction buffer, 10% NP40 and 3 μl
of PNGase F or water (for control reaction), samples
were incubated at 37°C for 2 hr. Samples were then ana-
lyzed by Western blot as described above.
Immunohistochemistry
Animals (38-45 day old rats) were deeply anesthetized
with 4% tribromoethanol (0.016 ml/g body weight i.p.)
and transcardially perfused with Cl- free solution (in
mM: 150 Na-gluconate, 1.6 K2HPO4, 0.4 KH2PO4, 4
Ca-gluconate, 1 MgSO4 and 5 glucose, pH 7.4) and
then with 4% paraformaldehyde in Cl- free solution. The
temporal bones were dissected. For whole temporal
bone cryosections, temporal bones were post fixed in
4% paraformaldehyde, decalcified for 24-72 hours in
10% (by weight) EDTA in PBS, processed through 10%-
30% sucrose gradient and incubated in 30% sucrose in
PBS. The temporal bones were embedded in TBS Tissue
Freezing Medium (#H-TFM, Triangle Biomedical
Sciences, Durham, NC), cryosectioned at 12 μm thick-
ness and mounted on ProbeON Plus charged glass slides
(#15-188-52, Fisher).
The slides were warmed for 3 hours at 37°C after
cryosectioning and then rehydrated with PBS. The tis-
sues were then permeabilized and blocked using the
blocking solution (PBS-TX: 0.2% Triton X-100, 5% BSA
in PBS) for 30 min. The sections were incubated over-
night at 4°C with the primary antibody (rabbit anti-
Trpv5 antibody [#CAT21A] or rabbit anti-Trpv6 anti-
body [#CAT11A], 1:100, Alpha Diagnostics, San Anto-
nio, TX) with or without blocking peptide ([#CAT21A]
and [#CAT11A], 1:4) in 0.2% PBS-TX with 2% BSA.
The sections were washed with PBS-TX and then incu-
bated in the dark with the secondary antibody (donkey
anti-rabbit Alexa 488 antibody, 1:1000, Molecular
Probes) for 1 hour at room temperature. Actin filaments
were visualized by staining with Alexa 594 conjugated
phalloidin (1:40, Molecular Probes). Finally, the sections
were washed with PBS-TX and overlaid with FluorSave
(Calbiochem, La Jolla, CA) and a cover glass. Sections
were observed with a confocal microscope (LSM510
Meta, Carl Zeiss, Germany).
Statistics
Data are presented as mean values ± SE from n observa-
tions. Student’s t-test was used to determine statistical
significance after the gene expression ratios were first
subjected to a logarithmic transformation to normalize
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the distribution. Paired or unpaired tests were per-
formed as appropriate for the specific data sets. Differ-
ences between means were considered significant for P
< 0.05.
Additional file 1: Fig. S1. Quality and degradation of extracellular RNA
and representative qRT-PCR.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1472-6793-10-1-
S1.PDF ]
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